Activation and evasion of innate immune response by rhabdoviruses

Biology and Pathogenesis of Rhabdo- and Filoviruses

Volumn , Issue , 2014, Pages 353-385

  Conzelmann, Karl Klaus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988661441     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789814635349_0015     Document Type: Chapter

References (187)

1. Fu, Z.F. Genetic comparison of the rhabdoviruses from animals and plants. Curr Top Microbiol Immunol 292, 1-24 (2005).
2. Schnell, M.J., McGettigan, J.P., Wirblich, C. & Papaneri, A. The cell biology of rabies virus: using stealth to reach the brain. Nat Rev Microbiol. 8, 51-61 (2010).
3. Lafon, M. Immune evasion, a critical strategy for rabies virus. Dev Biol (Basel) 131, 413-419 (2008).
4. Prehaud, C. et al. Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein. Sci Signal 3, ra5 (2010).
5. Callaway, E.M. Transneuronal circuit tracing with neurotropic viruses. Curr Opin Neurobiol 18, 617-623 (2008).
6. Ginger, M., Haberl, M., Conzelmann, K.K., Schwarz, M.K. & Frick, A. Revealing the secrets of neuronal circuits with recombinant rabies virus technology. Front Neural Circuits 7: 2 (2013).
7. Miest, T.S. & Cattaneo, R. New viruses for cancer therapy: meeting clinical needs. Nat Rev Microbiol 12, 23-34 (2014).
8. Luo, M., Green, T.J., Zhang, X., Tsao, J. & Qiu, S. Conserved characteristics of the rhabdovirus nucleoprotein. Virus Res 129, 246-251 (2007).
9. Albertini, A.A., Schoehn, G., Weissenhorn, W. & Ruigrok, R.W. Structural aspects of rabies virus replication. Cell Mol.Life Sci 65, 282-294 (2008).
10. Leppert, M., Rittenhouse, L., Perrault, J., Summers, D.F. & Kolakofsky, D. Plus and minus strand leader RNAs in negative strand virus-infected cells. Cell 18, 735-747 (1979).
11. Vidal, S. & Kolakofsky, D. Modified model for the switch from Sendai virus transcription to replication. J Virol 63, 1951-1958 (1989).
12. Janeway, C.A., Jr. & Medzhitov, R. Innate immune recognition. Annu Rev Immunol20, 197-216 (2002).
13. Goubau, D., Deddouche, S. & Sousa, R.e. Cytosolic sensing of viruses. Immunity38, 855-869 (2013).
14. Paludan, S.R. & Bowie, A.G. Immune sensing of DNA. Immunity 38, 870-880 (2013).
15. Melchjorsen, J. Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines. Viruses 5, 470-527 (2013).
16. Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11, 373-384 (2010).
17. Yoneyama, M. & Fujita, T. Recognition of viral nucleic acids in innate immunity. Rev Med Virol 20, 4-22 (2010).
18. Isaacs, A. & Lindenmann, J. Virus interference. I. The interferon. Proc. R. Soc. Lond B Biol.Sci. 147, 258-267 (1957).
19. Theofilopoulos, A.N., Baccala, R., Beutler, B. & Kono, D.H. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23, 307-335 (2005).
20. Le, B.A. & Tough, D.F. Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 14, 432-436 (2002).
21. Durbin, R.K., Kotenko, S.V. & Durbin, J.E. Interferon induction and function at the mucosal surface. Immunol Rev 255, 25-39 (2013).
22. Platanias, L.C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5, 375-386 (2005).
23. Schoggins, J.W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481-485 (2011).
24. Takaoka, A. et al. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 424, 516-523 (2003).
25. Goodbourn, S., Didcock, L. & Randall, R.E. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol. 81, 2341-2364 (2000).
26. Isaacs, A., Cox, R.A. & Rotem, Z. Foreign nucleic acids as the stimulus to make interferon. Lancet 2, 113-116 (1963).
27. Field, A.K., Tytell, A.A., Lampson, G.P. & Hilleman, M.R. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc Natl Acad Sci USA 58, 1004-1010 (1967).
28. Kerr, I.M., Brown, R.E. & Ball, L.A. Increased sensitivity of cell-free protein synthesis to double-stranded RNA after interferon treatment. Nature 250, 57-59 (1974).
29. Ablasser, A. et al. cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING. Nature 498, 380-384 (2013).
30. Honda, K. & Taniguchi, T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6, 644-658 (2006).
31. Perkins, N.D. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8, 49-62 (2007).
32. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in doublestranded RNA-induced innate antiviral responses. Nat Immunol 5, 730-737 (2004).
33. Andrejeva, J. et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 101, 17264-17269 (2004).
34. Motz, C. et al. Paramyxovirus V proteins disrupt the fold of the RNA sensor MDA5 to inhibit antiviral signaling. Science. 339, 690-693 (2013).
35. Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101-105 (2006).
36. Kim, D.H. et al. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat Biotechnol 22, 321-325 (2004).
37. Hornung, V. et al. 5'-Triphosphate RNA is the ligand for RIG-I. Science 314, 994-997 (2006).
38. Pichlmair, A. et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 314, 997-1001 (2006).
39. Wilkins, C. & Gale, M., Jr. Recognition of viruses by cytoplasmic sensors. Curr Opin Immunol 22, 41-47 (2010).
40. Sumpter, R., Jr. et al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol79, 2689-2699 (2005).
41. Kolakofsky, D., Kowalinski, E. & Cusack, S. A structure-based model of RIG-I activation. RNA 18, 2118-2127 (2012).
42. Cui, S. et al. The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. Mol Cell 29, 169-179 (2008).
43. Pippig, D.A. et al. The regulatory domain of the RIG-I family ATPase LGP2 senses double-stranded RNA. Nucleic Acids Res 37, 2014-2025 (2009).
44. Li, X. et al. Structural basis of double-stranded RNA recognition by the RIG-I like receptor MDA5. Arch. Biochem. Biophys. 488, 23-33 (2009).
45. Schmidt, A. et al. 5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci USA 106, 12067-12072 (2009).
46. Myong, S. et al. Cytosolic viral sensor RIG-I is a 5'-triphosphate-dependent translocase on double-stranded RNA. Science 323, 1070-1074 (2009).
47. Gack, M.U. et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-Imediated antiviral activity. Nature 446, 916-920 (2007).
48. Kawai, T. et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6, 981-988 (2005).
49. Marq, J.B., Hausmann, S., Veillard, N., Kolakofsky, D. & Garcin, D. Short doublestranded RNAs with an overhanging 5’ ppp-nucleotide, as found in arenavirus genomes, act as RIG-I decoys. J Biol Chem 286, 6108-6116 (2011).
50. Schlee, M. et al. Recognition of 5’ Triphosphate by RIG-I Helicase Requires Short Blunt Double-Stranded RNA as Contained in Panhandle of Negative-Strand Virus. Immunity 31, 25-34 (2009).
51. Schlee, M. Master sensors of pathogenic RNA - RIG-I like receptors. Immunobiol218, 1322-1335 (2013).
52. Wu, B. et al. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 152, 276-289 (2013).
53. Berke, I.C., Yu, X., Modis, Y. & Egelman, E.H. MDA5 assembles into a polar helical filament on dsRNA. Proc Natl Acad Sci USA 109, 18437-18441 (2012).
54. Kohlway, A., Luo, D., Rawling, D.C., Ding, S.C. & Pyle, A.M. Defining the functional determinants for RNA surveillance by RIG-I. EMBO Rep 14, 772-779 (2013).
55. Hou, F. et al. MAVS Forms Functional Prion-like Aggregates to Activate and Propagate Antiviral Innate Immune Response. Cell 146, 448-461 (2011).
56. Dixit, E. et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141, 668-681 (2010).
57. Kato, H. et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205, 1601-1610 (2008).
58. Liu, S. et al. MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. Elife. 2, e00785 (2013).
59. Zhao, T. et al. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat Immunol 8, 592-600 (2007).
60. Sharma, S. et al. Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148-1151 (2003).
61. Fitzgerald, K.A. et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4, 491-496 (2003).
62. Freaney, J.E., Kim, R., Mandhana, R. & Horvath, C.M. Extensive cooperation of immune master regulators IRF3 and NFkappaB in RNA Pol II recruitment and pause release in human innate antiviral transcription. Cell Rep 4, 959-973 (2013).
63. Panne, D., Maniatis, T. & Harrison, S.C. An atomic model of the interferon-beta enhanceosome. Cell 129, 1111-1123 (2007).
64. Sato, M. et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13, 539-548 (2000).
65. Rehwinkel, J. et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140, 397-408 (2010).
66. Fujita, T., Onoguchi, K., Onomoto, K., Hirai, R. & Yoneyama, M. Triggering antiviral response by RIG-I-related RNA helicases. Biochimie 89, 754-760 (2007).
67. Loo, Y.M. et al. Distinct RIG-I and MDA5 Signaling by RNA Viruses in Innate Immunity. J Virol 82, 335-345 (2007).
68. Strahle, L. et al. Activation of the Beta Interferon Promoter by Unnatural Sendai Virus Infection Requires RIG-I and Is Inhibited by Viral C Proteins. J Virol 81, 12227-12237 (2007).
69. Yoneyama, M. et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175, 2851-2858 (2005).
70. Gitlin, L. et al. Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo. PLoS. Pathog 6, e1000734 (2010).
71. Ikegame, S. et al. Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol 84, 372-379 (2010).
72. Faul, E.J. et al. Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS. Pathog 6, e1001016 (2010).
73. Boonyaratanakornkit, J. et al. The C proteins of human parainfluenza virus type 1 limit double-stranded RNA accumulation that would otherwise trigger activation of MDA5 and protein kinase R. J Virol 85, 1495-1506 (2011).
74. Ostertag, D., Hoblitzell-Ostertag, T.M. & Perrault, J. Overproduction of doublestranded RNA in vesicular stomatitis virus-infected cells activates a constitutive cell-type-specific antiviral response. J Virol 81, 503-513 (2007).
75. Rodriguez, K.R. & Horvath, C.M. Amino acid requirements for MDA5 and LGP2 recognition by paramyxovirus V proteins: a single arginine distinguishes MDA5 from RIG-I. J Virol 87, 2974-2978 (2013).
76. Childs, K. et al. mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359, 190-200 (2007).
77. Pfaller, C.K., Radeke, M.J., Cattaneo, R. & Samuel, C.E. Measles Virus C Protein Impairs Production of Defective Copyback Double-stranded Viral RNA and Activation of Protein Kinase R. J Virol (2013).
78. Weber, F., Wagner, V., Rasmussen, S.B., Hartmann, R. & Paludan, S.R. Doublestranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 80, 5059-5064 (2006).
79. Weber, M. et al. Incoming RNA virus nucleocapsids containing a 5'- triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe13, 336-346 (2013).
80. Gerlier, D. & Lyles, D.S. Interplay between innate immunity and negative-strand RNA viruses: towards a rational model. Microbiol Mol Biol Rev 75, 468-490 (2011).
81. Plumet, S. et al. Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS ONE 2, e279 (2007).
82. Plumet, S., Duprex, W.P. & Gerlier, D. Dynamics of Viral RNA Synthesis during Measles Virus Infection. J Virol 79, 6900-6908 (2005).
83. Blumberg, B.M. & Kolakofsky, D. Intracellular vesicular stomatitis virus leader RNAs are found in nucleocapsid structures. J Virol 40, 568-576 (1981).
84. Finke, S. & Conzelmann, K.K. Virus promoters determine interference by defective RNAs: selective amplification of mini-RNA vectors and rescue from cDNA by a 3’ copy-back ambisense rabies virus. J Virol 73, 3818-3825 (1999).
85. Lazzarini, R.A., Keene, J.D. & Schubert, M. The origins of defective interfering particles of the negative-strand RNA viruses. Cell 26, 145-154 (1981).
86. Perrault, J. Origin and replication of defective interfering particles. Curr Top Microbiol Immunol 93, 151-207 (1981).
87. Marcus, P.I. & Sekellick, M.J. Defective interfering particles with covalently linked [+/-]RNA induce interferon. Nature 266, 815-819 (1977).
88. Sekellick, M.J. & Marcus, P.I. Interferon induction by viruses. VIII. Vesicular stomatitis virus: [+/-]DI-011 particles induce interferon in the absence of standard virions. Virology 117, 280-285 (1982).
89. Panda, D., Dinh, P.X., Beura, L.K. & Pattnaik, A.K. Induction of interferon and interferon signaling pathways by replication of defective interfering particle RNA in cells constitutively expressing vesicular stomatitis virus replication proteins. J Virol84, 4826-4831 (2010).
90. Strahle, L., Garcin, D. & Kolakofsky, D. Sendai virus defective-interfering genomes and the activation of interferon-beta. Virology 351, 101-111 (2006).
91. Killip, M.J. et al. Failure to activate the IFN-beta promoter by a paramyxovirus lacking an interferon antagonist. Virology. 415, 39-46 (2011).
92. Georgel, P. et al. Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. Virology 362, 304-313 (2007).
93. Kurt-Jones, E.A. et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1, 398-401 (2000).
94. Uematsu, S. & Akira, S. Toll-like receptors and Type I interferons. J Biol Chem 282, 15319-15323 (2007).
95. Honda, K. et al. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci USA 101, 15416-15421 (2004).
96. Kawai, T. et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5, 1061-1068 (2004).
97. Hornung, V. et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168, 4531-4537 (2002).
98. Lund, J.M. et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA 101, 5598-5603 (2004).
99. Barchet, W. et al. Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. J Exp Med 195, 507-516 (2002).
100. Lee, H.K., Lund, J.M., Ramanathan, B., Mizushima, N. & Iwasaki, A. Autophagydependent viral recognition by plasmacytoid dendritic cells. Science 315, 1398-1401 (2007).
101. Sun, Q. et al. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24, 633-642 (2006).
102. Zhou, S. et al. Role of MyD88 in route-dependent susceptibility to vesicular stomatitis virus infection. J Immunol 178, 5173-5181 (2007).
103. Shi, Z. et al. A novel Toll-like receptor that recognizes vesicular stomatitis virus. J Biol Chem 286, 4517-4524 (2011).
104. Hornung, V. et al. Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virus. J Immunol 173, 5935-5943 (2004).
105. Li, J., Faber, M., Dietzschold, B. & Hooper, D.C. The role of toll-like receptors in the induction of immune responses during rabies virus infection. Adv Virus Res 79, 115-126 (2011).
106. Edelmann, K.H. et al. Does Toll-like receptor 3 play a biological role in virus infections? Virology 322, 231-238 (2004).
107. Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640-643 (2003).
108. Yamamoto, M. et al. TRAM is specifically involved in the Toll-like receptor 4- mediated MyD88-independent signaling pathway. Nat Immunol 4, 1144-1150 (2003).
109. Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T. & Seya, T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 4, 161-167 (2003).
110. Fitzgerald, K.A. et al. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med 198, 1043-1055 (2003).
111. Schabbauer, G. et al. TLR4/CD14-mediated PI3K activation is an essential component of interferon-dependent VSV resistance in macrophages. Mol Immunol45, 2790-2796 (2008).
112. Menager, P. et al. Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies. PLoS Pathog 5, e1000315 (2009).
113. Versteeg, G.A. & Garcia-Sastre, A. Viral tricks to grid-lock the type I interferon system. Curr Opin Microbiol 13, 508-516 (2010).
114. Randall, R.E. & Goodbourn, S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89, 1-47 (2008).
115. Masatani, T. et al. Importance of rabies virus nucleoprotein in viral evasion of interferon response in the brain. Microbiol Immunol. 57, 511-517 (2013).
116. Killip, M.J. et al. Deep sequencing analysis of defective genomes of parainfluenza virus 5 and their role in interferon induction. J Virol 87, 4798-4807 (2013).
117. Killip, M.J., Young, D.F., Precious, B.L., Goodbourn, S. & Randall, R.E. Activation of the beta interferon promoter by paramyxoviruses in the absence of virus protein synthesis. J Gen Virol 93, 299-307 (2012).
118. Lynch, S. & Kolakofsky, D. Ends of the RNA within Sendai virus defective interfering nucleocapsids are not free. J Virol 28, 584-589 (1978).
119. Pollin, R., Granzow, H., Kollner, B., Conzelmann, K.K. & Finke, S. Membrane and inclusion body targeting of lyssavirus matrix proteins. Cell Microbiol 15, 200-212 (2013).
120. Lahaye, X. et al. Functional characterization of Negri bodies (NBs) in rabies virusinfected cells: Evidence that NBs are sites of viral transcription and replication. J Virol 83, 7948-7958 (2009).
121. Heinrich, B.S., Cureton, D.K., Rahmeh, A.A. & Whelan, S.P. Protein expression redirects vesicular stomatitis virus RNA synthesis to cytoplasmic inclusions. PLoS Pathog 6, e1000958 (2010).
122. Onomoto, K. et al. Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLoS ONE. 7, e43031 (2012).
123. Wagner, R.R. & Huang, A.S. Inhibition of RNA and interferon synthesis in Krebs-2 cells infected with vesicular stomatitis virus. Virology 28, 1-10 (1966).
124. Wertz, G.W. & Youngner, J.S. Interferon production and inhibition of host synthesis in cells infected with vesicular stomatitis virus. J Virol 6, 476-484 (1970).
125. Black, B.L., Rhodes, R.B., McKenzie, M. & Lyles, D.S. The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its function in virus assembly. J Virol 67, 4814-4821 (1993).
126. Blondel, D., Harmison, G.G. & Schubert, M. Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J Virol 64, 1716-1725 (1990).
127. Black, B.L. & Lyles, D.S. Vesicular stomatitis virus matrix protein inhibits host celldirected transcription of target genes in vivo. J Virol 66, 4058-4064 (1992).
128. Yuan, H., Yoza, B.K. & Lyles, D.S. Inhibition of host RNA polymerase IIdependent transcription by vesicular stomatitis virus results from inactivation of TFIID. Virology 251, 383-392 (1998).
129. Ferran, M.C. & Lucas-Lenard, J.M. The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter. J Virol 71, 371-377 (1997).
130. Ahmed, M. et al. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J Virol 77, 4646-4657 (2003).
131. Petersen, J.M., Her, L.S., Varvel, V., Lund, E. & Dahlberg, J.E. The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes. Mol Cell Biol 20, 8590-8601 (2000).
132. von Kobbe, C. et al. Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98. Mol Cell 6, 1243-1252 (2000).
133. Enninga, J., Levy, D.E., Blobel, G. & Fontoura, B.M. Role of nucleoporin induction in releasing an mRNA nuclear export block. Science 295, 1523-1525 (2002).
134. Faria, P.A. et al. VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Mol Cell 17, 93-102 (2005).
135. Marcus, P.I., Rodriguez, L.L. & Sekellick, M.J. Interferon induction as a quasispecies marker of vesicular stomatitis virus populations. J Virol 72, 542-549 (1998).
136. Marcus, P.I., Engelhardt, D.L., Hunt, J.M. & Sekellick, M.J. Interferon action: inhibition of vesicular stomatitis virus RNA synthesis induced by virion-bound polymerase. Science 174, 593-598 (1971).
137. Publicover, J., Ramsburg, E., Robek, M. & Rose, J.K. Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: viral pathogenesis is linked to induction of tumor necrosis factor alpha. J Virol 80, 7028-7036 (2006).
138. Ahmed, M., Brzoza, K.L. & Hiltbold, E.M. Matrix protein mutant of vesicular stomatitis virus stimulates maturation of myeloid dendritic cells. J Virol 80, 2194-2205 (2006).
139. Hastie, E. & Grdzelishvili, V.Z. Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer. J Gen Virol 93, 2529-2545 (2012).
140. Wickersham, I.R. et al. Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons. Neuron 53, 639-647 (2007).
141. Mebatsion, T., Weiland, F. & Conzelmann, K.K. Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J Virol 73, 242-250 (1999).
142. Mebatsion, T., König, M. & Conzelmann, K.K. Budding of rabies virus particles in the absence of the spike glycoprotein. Cell 84, 941-951 (1996).
143. Finke, S., Mueller-Waldeck, R. & Conzelmann, K.K. Rabies virus matrix protein regulates the balance of virus transcription and replication. J Gen Virol 84, 1613-1621 (2003).
144. Luco, S. et al. RelAp43, a member of the NF-kappaB family involved in innate immune response against Lyssavirus infection. PLoS Pathog 8, e1003060 (2012).
145. Raux, H., Flamand, A. & Blondel, D. Interaction of the rabies virus P protein with the LC8 dynein light chain. J Virol 74, 10212-10216 (2000).
146. Jacob, Y., Badrane, H., Ceccaldi, P.E. & Tordo, N. Cytoplasmic dynein LC8 interacts with lyssavirus phosphoprotein. J Virol 74, 10217-10222 (2000).
147. Chenik, M., Chebli, K. & Blondel, D. Translation initiation at alternate in-frame AUG codons in the rabies virus phosphoprotein mRNA is mediated by a ribosomal leaky scanning mechanism. J Virol 69, 707-712 (1995).
148. Pasdeloup, D. et al. Nucleocytoplasmic shuttling of the rabies virus P protein requires a nuclear localization signal and a CRM1-dependent nuclear export signal. Virology 334, 284-293 (2005).
149. Vidy, A., El Bougrini, J., Chelbi-Alix, M.K. & Blondel, D. The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J Virol 81, 4255-4263 (2007).
150. Moseley, G.W., Filmer, R.P., Dejesus, M.A. & Jans, D.A. Nucleocytoplasmic Distribution of Rabies Virus P-Protein Is Regulated by Phosphorylation Adjacent to C-Terminal Nuclear Import and Export Signals. Biochemistry 46, 12053-12061 (2007).
151. Brzózka, K., Finke, S. & Conzelmann, K.K. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol 79, 7673-7681 (2005).
152. Pfaller, C.K. & Conzelmann, K.K. Measles virus V protein is a decoy substrate for IkappaB kinase alpha and prevents Toll-like receptor 7/9-mediated interferon induction. J Virol 82, 12365-12373 (2008).
153. Brzózka, K., Finke, S. & Conzelmann, K.K. Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2. J Virol 80, 2675-2683 (2006).
154. Lieu, K.G. et al. The rabies virus interferon antagonist P protein interacts with activated STAT3 and inhibits Gp130 receptor signaling. J Virol 87, 8261-8265 (2013).
155. Wiltzer, L. et al. Conservation of a Unique Mechanism of Immune Evasion across the Lyssavirus Genus. J Virol 86, 10194-10199 (2012).
156. Moseley, G.W. et al. Dual modes of rabies P-protein association with microtubules: a novel strategy to suppress the antiviral response. J Cell Sci 122, 3652-3662 (2009).
157. Vidy, A., Chelbi-Alix, M. & Blondel, D. Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J Virol 79, 14411-14420 (2005).
158. Rieder, M. et al. Genetic dissection of interferon-antagonistic functions of rabies virus phosphoprotein: inhibition of interferon regulatory factor 3 activation is important for pathogenicity. J Virol 85, 842-852 (2011).
159. Marschalek, A. et al. Attenuation of rabies virus replication and virulence by picornavirus internal ribosome entry site elements. J Virol 83, 1911-1919 (2009).
160. Marschalek, A., Drechsel, L. & Conzelmann, K.K. The importance of being short: the role of rabies virus phosphoprotein isoforms assessed by differential IRES translation initiation. Eur J Cell Biol 91, 17-23 (2012).
161. Ito, N. et al. The Role of Interferon-Antagonist Activity of Rabies Virus Phosphoprotein in Viral Pathogenicity. J Virol 84, 6699-6710 (2010).
162. Wiltzer, L. et al. Interaction of Rabies Virus P-Protein With STAT Proteins is Critical to Lethal Rabies Disease. J Inf Dis 209,1744-53 (2014).
163. Chopy, D., Detje, C.N., Lafage, M., Kalinke, U. & Lafon, M. The type I interferon response bridles rabies virus infection and reduces pathogenicity. J Neurovirol 17, 353-367 (2011).
164. Chopy, D. et al. Ambivalent role of the innate immune response in rabies virus pathogenesis. J Virol 85, 6657-6668 (2011).
165. Boxel-Dezaire, A.H., Rani, M.R. & Stark, G.R. Complex modulation of cell typespecific signaling in response to type I interferons. Immunity 25, 361-372 (2006).
166. Schoggins, J.W. et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505, 691-5 (2013).
167. Schoggins, J.W. & Rice, C.M. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 1, 519-525 (2011).
168. Stojdl, D.F. et al. The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. J Virol 74, 9580-9585 (2000).
169. Lee, S.B., Bablanian, R. & Esteban, M. Regulated expression of the interferoninduced protein kinase p68 (PKR) by vaccinia virus recombinants inhibits the replication of vesicular stomatitis virus but not that of poliovirus. J Interferon Cytokine Res 16, 1073-1078 (1996).
170. Balachandran, S. et al. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13, 129-141 (2000).
171. Sen, G.C. & Peters, G.A. Viral stress-inducible genes. Adv Virus Res 70, 233-263 (2007).
172. Blondel, D., Kheddache, S., Lahaye, X., Dianoux, L. & Chelbi-Alix, M.K. Resistance to rabies virus infection conferred by the PMLIV isoform. J Virol 84, 10719-10726 (2010).
173. Chelbi-Alix, M.K., Quignon, F., Pelicano, L., Koken, M.H. & de The, H. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J Virol 72, 1043-1051 (1998).
174. Blondel, D. et al. Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 21, 7957-7970 (2002).
175. Haller, O. Dynamins are forever: MxB inhibits HIV-1. Cell Host Microbe. 14, 371-373 (2013).
176. Haller, O. & Kochs, G. Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J.Interferon Cytokine Res. 31, 79-87 (2011).
177. Leroy, M., Pire, G., Baise, E. & Desmecht, D. Expression of the interferonalpha/ beta-inducible bovine Mx1 dynamin interferes with replication of rabies virus. Neurobiol Dis 21, 515-521 (2006).
178. Ward, S.V. et al. RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis. Proc Natl Acad Sci USA 108, 331-336 (2011).
179. Silverman, R.H. Viral Encounters with OAS and RNase L during the IFN Antiviral Response. J Virol 81, 12720-12729 (2007).
180. Bego, M.G., Mercier, J. & Cohen, E.A. Virus-activated interferon regulatory factor 7 upregulates expression of the interferon-regulated BST2 gene independently of interferon signaling. J Virol 86, 3513-3527 (2012).
181. Sarojini, S., Theofanis, T. & Reiss, C.S. Interferon-induced tetherin restricts vesicular stomatitis virus release in neurons. DNA Cell Biol 30, 965-974 (2011).
182. Swiecki, M., Wang, Y., Gilfillan, S., Lenschow, D.J. & Colonna, M. Cutting edge: paradoxical roles of BST2/tetherin in promoting type I IFN response and viral infection. J Immunol 188, 2488-2492 (2012).
183. Amini-Bavil-Olyaee et al. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 13, 452-464 (2013).
184. Weidner, J.M. et al. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol84, 12646-12657 (2010).
185. Kimura, T. et al. Ifit1 inhibits Japanese encephalitis virus replication through binding to 5’ capped 2'-O unmethylated RNA. J Virol 87, 9997-10003 (2013).
186. Diamond, M.S. & Farzan, M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol 13, 46-57 (2013).
187. Komarova, A.V. et al. Identification of RNA partners of viral proteins in infected cells. RNA Biol 10, 944-956 (2013).